GASTROESOPHAGEAL JUNCTION
Clinical trials for GASTROESOPHAGEAL JUNCTION explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stomach cancer: experimental drug combo trial opens
Disease control Recruiting nowThis study tests new experimental drugs combined with standard chemotherapy and immunotherapy for people with advanced stomach, gastroesophageal junction, or esophageal cancer that cannot be removed by surgery or has spread. About 160 participants will receive the combination to …
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo shows promise for Tough-to-Treat stomach cancers
Disease control Recruiting nowThis Phase 2 trial is testing a new drug called denikitug, alone or combined with other cancer drugs, in 120 people with advanced HER2-negative stomach, gastroesophageal junction, or esophageal cancer that has worsened after initial treatment. The main goal is to see if the drug …
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for advanced stomach cancer: experimental drug combos enter human trials
Disease control Recruiting nowThis study tests two new drug combinations for people with advanced stomach, gastroesophageal junction, or esophageal cancer that has worsened after initial treatment. About 210 participants will receive either an experimental antibody-drug conjugate plus chemotherapy, or a stand…
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New scan aims to spot hidden cancer spread in stomach and esophageal tumors
Diagnosis Recruiting nowThis study is testing a new type of PET/CT scan called [¹⁸F]FAPI-74 to see if it can better detect when stomach or esophageal cancer has spread to other parts of the body. About 200 adults with these cancers will receive one dose of the scan tracer and be followed for up to 3 mon…
Matched conditions: GASTROESOPHAGEAL JUNCTION
Phase: PHASE3 • Sponsor: SOFIE • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC